pramipexole has been researched along with amg 009 in 1 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (amg 009) | Trials (amg 009) | Recent Studies (post-2010) (amg 009) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 11 | 0 | 10 |
| Protein | Taxonomy | pramipexole (IC50) | amg 009 (IC50) |
|---|---|---|---|
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 1.1 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.012 | |
| Prostaglandin D2 receptor | Homo sapiens (human) | 0.0094 | |
| Chemoattractant receptor-homologous molecule expressed on Th2 cells | Cavia porcellus (domestic guinea pig) | 0.003 | |
| Prostaglandin D2 receptor 2 | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 other study(ies) available for pramipexole and amg 009
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |